SCHEMBL11899536

SCHEMBL11899536

OCCc1cc(Nc2ccc(F)cc2)nc(N/N=C/c2ccccc2O)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDX3X O00571 8/20 1.00
▸ KMT2A Q03164 7/20 0.58
▸ MEN1 O00255 6/20 0.58
▸ KDM4E B2RXH2 5/20 0.58
▸ MAPT P10636 4/20 0.58
▸ HTT P42858 2/20 0.58
▸ POLB P06746 2/20 0.58
▸ BLM P54132 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ LMNA P02545 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ GAA P10253 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ GFER P55789 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1658047 1.00 DDX3X (1.00) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL1655150 0.83 DDX3X (0.70) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL11898667 0.81 KMT2A (0.83) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL11898668 0.81 KMT2A (0.83) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL5616533 0.71 MAPT (0.57) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL11913687 0.70 DDX3X (0.53) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL22903887 0.70 KDM4E (0.74) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL11899415 0.69 MAPT (0.64) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL11899414 0.69 MAPT (0.64) DDX3XKMT2AMEN1KDM4EMAPT
SCHEMBL6421066 0.68 KMT2A (0.54) DDX3XKMT2AMEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B DDX3X 1/4885KMT2A 2610/4885MEN1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback